| |
PositiveID Corporation (OTCBB: PSID) $0.015. Announced Monday after market close an update to its stockholders on its pursuit of BioWatch Generation 3, Phase II. Two weeks ago, the Department of Homeland Security ("DHS") revised its procurement strategy for BioWatch Generation 3, Phase II, which now will consist of a two-stage procurement which includes two to three years of testing estimated at $89 million. A draft request for proposal ("RFP") on this effort is scheduled for release in the fourth quarter of calendar 2012. PositiveID's patented M-BAND biodetector was developed under a competitive award from the DHS Science & Technology Directorate ("S&T").
The purpose of BioWatch Generation 3, Phase II is to obtain a fully autonomous networked biodetection capability that will be deployed, operated, and sustained, both indoor and outdoor, in selected U.S. BioWatch jurisdictions to continuously monitor the air for agents of biological concern. The original procurement outlined in the draft solicitation released by DHS in August 2011, with an estimated contract value of $3.1 billion, contemplated a single procurement resulting in a single award Indefinite Delivery Indefinite Quantity (IDIQ) contract for Performance Testing, Low Rate Initial Production (LRIP), Operational Test & Evaluation (OT&E), Detector Production, Deployment, Sustainment and Disposal.
The revised strategy, released by DHS two weeks ago, would consist of a two-stage procurement using a competitive down-selection between stages. Stage 1 would be for Performance Testing of candidate systems and may result in the award of multiple contracts depending on the technical merits of proposals submitted and the availability of funding. Stage 2 would be a separate competition and result in the award of a single contract for LRIP, OT&E, Full Rate Production, Deployment, Sustainment and Disposal. To be considered for the Stage 2 award, a company would need to demonstrate a design maturity and data set equivalent to that of Stage 1 participants.
William J. Caragol, Chairman and CEO of PositiveID, stated,"We believe the revised strategy for BioWatch, allowing for performance testing of qualifying systems in preparation for the full roll-out of the $3.1 billion procurement, provides us an opportunity to prove our M-BAND system, the only system of its kind that was demonstrated previously in the field under the DHS S&T BAND Program. Additionally, we continue to have discussions with potential strategic partners to prepare the Company for success in BioWatch Gen-3, Phase II."
What They Do: PositiveID Corporation is an emerging growth company and developer of airborne bio-threat detection systems for America's homeland defense industry as well as advanced technologies for diabetes management and rapid medical testing.
Its wholly-owned subsidiary, Microfluidic Systems, is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.
TiVo Inc. ( Nasdaaq : TIVO ) $9.94. Today announced that it has settled its pending patent litigation with Verizon Communications Inc. and that the companies have entered into a mutual patent licensing arrangement. Under the terms of the settlement, Verizon will provide TiVo total compensation worth at least $250.4 million. The payments from Verizon to TiVo shall be comprised of a $100 million initial cash payment followed by recurring quarterly payments totaling an additional $150.4 million through July 2018. If the companies pursue certain commercial initiatives prior to December 21, 2012, up to $29.4 million of the payments made by Verizon would be subject to a credit of an equal amount.
In addition to the guaranteed compensation, Verizon will also pay monthly license fees through July 2018 for each Verizon DVR subscriber in excess of certain pre-determined levels.In addition to the cash payments described above, Verizon and TiVo are exploring, among other things, future distribution of Internet video services developed through Verizon's joint venture with Redbox by making content distributed via that service part of the diverse selection of linear and broadband-delivered content accessible to users of TiVo's retail DVR products.
What They Do: TiVo Inc. developed the first commercially available digital video recorder (DVR). Today TiVo is a global leader in advanced television service for virtually any platform or device.
Regal Entertainment Group (NYSE: RGC) $14.03. Announced Monday after market close a milestone with 200 theatres nationwide now offering the Sony Entertainment Access System at theatres across the country. Regal Entertainment Group is working exclusively with Sony for this cutting-edge technology to assist moviegoers who are deaf, hard of hearing, have low vision or are blind.“Regal is leading the way by providing the best experience available for all of our guests. This technology, designed by the experts at Sony, is revolutionary in terms of greater access for moviegoers,” stated Ken Thewes, Regal Entertainment Group Chief Marketing Officer. “We expect to deploy this equipment to all of our digital cinemas by April and we are encouraged by the positive feedback already received regarding the new technology.”
“With Sony’s entertainment access glasses, a broader range of the moviegoing public can now enjoy exciting movie experiences in a relaxed, natural way without the inconvenience of separate screening times or special seating,” said Dianne LaGuardia, senior marketing manager for digital cinema at Sony Electronics. “We’re proud to be working with Regal to rollout this revolutionary technology.”
The system includes specially designed lightweight eyewear for guests who are deaf or hard of hearing to privately view closed captioned text directly in their line of sight for both 2D and 3D movies. This assistive technology can accommodate headphones or neck loops connected to the wireless receiver to hear descriptive audio tracks for patrons who have low vision or those who are blind.
What They Do: Regal Entertainment Group operates the largest and most geographically diverse theatre circuit in the United States, consisting of 6,597 screens in 522 locations in 37 states and the District of Columbia as of August 30, 2012.
Copyright SmallCapReview.
SmallCapReview.com is a leading site for news on small-caps, penny stocks and microcaps. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select stocks in play, to register visit smallcapreview.com.Copyright SmallCapReview. SmallCapReview.com has been a leading site for information on Small Cap Stocks, Penny Stocks and Microcaps since 1999. Visit SmallCapReview.com to sign up for our FREE newsletter. SmallCapReview has been compensated three thousand five hundred dollars by a third party HFS for its efforts with regards to PositiveID Corporation.
|
editor[.]smallcapreview.com 
